InvestorsHub Logo
Followers 40
Posts 1456
Boards Moderated 0
Alias Born 09/23/2013

Re: None

Monday, 09/30/2013 12:41:40 PM

Monday, September 30, 2013 12:41:40 PM

Post# of 144817
Another apparent advantage for Nuvilex's treatment compared to the ABRAXANE-gemcitabine combination concerns the side effects (toxicities) associated with both treatments. Significant and severe drug-associated toxicities were seen with the ABRAXANE-gemcitabine combination, whereas with Nuvilex's treatment, side effects were essentially non-existent. The lack of side effects from live-cell encapsulation-ifosfamide combination is undoubtedly related to the low dose of ifosfamide used.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News